OriGene Logo
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-WT1 antibodies

Anti-WT1 Antibody 6F-H2

div

Specifications Citations Customer Reviews Product Documents
SKU Description Amount Price Availability*  
TA301555 Mouse Monoclonal Antibody against Wilms Tumor 1 (6F-H2) 100ul $325 2 Weeks
Add to Shopping Cart
spacer
WB(1)
IHC(1)

OriGene Data

ImmunogenHuman recombinant WT1 protein (residues 1-181). [Swiss-Prot# P19544]
Clone Name6F-H2 IsotypeIgG1 kappa
Species Reactivityhuman ConcentrationLot dependent; please refer to CoA along with shipment
Guaranteed Application *WB, IHC Suggested DilutionsWB: 2 ug/ml
BufferTris-glycine, 150mM NaCl and 0.05% sodium azide
Purification IgG purified

Reference Data

Target NameHomo sapiens Wilms tumor 1 (WT1), transcript variant D
Alternative NameAWT1; EWS-WT1; GUD; NPHS4; WAGR; WIT-2; WT33
Database LinkNP_077744
Entrez Gene 7490 Human
FunctionWilms?tumor (WT) is an embryonal malignancy of the kidney that affects 1 in 10,000 infants and, like retinoblastoma, is observed in both sporadic and inherited forms. The Wilms?tumor locus has been mapped at chromosome 11p13 as a tumor suppressor gene which encodes a DNA binding protein with four zinc fingers and a glutamine-proline rich amino terminus. The Wilms?tumor protein binds the DNA sequence GCGGGGGCG, a recognition element common to the early growth response (Egr) family of Zn2+ finger transcriptional activators. However, in contrast to Egr transcription factors, WT1 behaves as a transcriptional repressor in transient transfection assays with synthetic promotor constructs.
Related PathwayTranscription FactorsDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.


WB Image
Western Blot- Wilms Tumor 1 Antibody (6F-H2) detects WT1 in 293 cell lysate
grey_line

IHC Image
Immunohistochemistry- IHC analysis of Wilms Tumor 1 in human renal cancer using DAB with hematoxylin counterstain.
grey_line

 

spacer
Inc 5000 Healthcare Company

Notice to Non-US Customers

ExclaimationWeb price and delivery time are for direct sales only.

Non-US customers are encouraged to contact our dedicated distributor network for quotes and streamlined ordering/delivery support.

Acknowledge